Literature DB >> 20923625

New antipsychotic drugs: how do their receptor-binding profiles compare?

Elliott Richelson1.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20923625     DOI: 10.4088/JCP.10ac06470yel

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  6 in total

1.  Cognitive efficacy of quetiapine in early-onset first-episode psychosis: a 12-week open label trial.

Authors:  Sébastien Urben; Pierre Baumann; Sandra Barcellona; Muriel Hafil; Ulrich Preuss; Claire Peter-Favre; Stéphanie Clarke; Olivier Halfon; Laurent Holzer
Journal:  Psychiatr Q       Date:  2012-09

Review 2.  Paliperidone extended release: in adolescents with schizophrenia.

Authors:  Caroline M Perry
Journal:  Paediatr Drugs       Date:  2012-12-01       Impact factor: 3.022

Review 3.  Oral paliperidone: a review of its use in the management of schizoaffective disorder.

Authors:  Lily P H Yang
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

Review 4.  Clozapine as a Model for Antipsychotic Development.

Authors:  Frederick C Nucifora; Marina Mihaljevic; Brian J Lee; Akira Sawa
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

5.  Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.

Authors:  Koen Demyttenaere; Johan Detraux; Giorgio Racagni; Kristof Vansteelandt
Journal:  CNS Drugs       Date:  2019-06       Impact factor: 5.749

6.  The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis.

Authors:  Henry A Nasrallah; Willie Earley; Andrew J Cutler; Yao Wang; Kaifeng Lu; István Laszlovszky; György Németh; Suresh Durgam
Journal:  BMC Psychiatry       Date:  2017-08-24       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.